Valuation: Yuhan Corporation

Capitalization 8,711B 5.93B 5.05B 4.72B 4.43B 8.17B 538B 8.93B 55.04B 21.28B 253B 22.26B 21.8B 921B P/E ratio 2025 *
72x
P/E ratio 2026 * 55.3x
Enterprise value 8.62B 5.87M 4.99M 4.67M 4.39M 8.08M 532M 8.83M 54.45M 21.05M 251M 22.03M 21.56M 911M EV / Sales 2025 *
3.84x
EV / Sales 2026 * 3.49x
Free-Float
67.64%
Yield 2025 *
0.43%
Yield 2026 * 0.43%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.26%
1 week-0.51%
Current month-4.34%
1 month-6.64%
3 months-2.51%
6 months+9.58%
Current year-2.34%
More quotes
1 week 115,600
Extreme 115600
117,500
1 month 114,200
Extreme 114200
125,500
Current year 100,400
Extreme 100400
140,700
1 year 100,400
Extreme 100400
140,700
3 years 47,571.43
Extreme 47571.4286
166,900
5 years 47,571.43
Extreme 47571.4286
166,900
10 years 24,550.49
Extreme 24550.4865
166,900
More quotes
Manager TitleAgeSince
Chief Executive Officer 70 2021-03-18
Director of Finance/CFO 57 -
President 66 2024-03-14
Director TitleAgeSince
Chairman 74 2021-03-18
Director/Board Member 70 2015-03-19
Director/Board Member 61 2020-02-29
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-0.26%-0.51%-2.59%+115.51% 5.91B
+0.17%-1.70%-15.98%-37.58% 60.15B
+0.84%+1.26%+6.71%-18.25% 8.58B
+1.99%+0.91%+32.10%+11.26% 7.32B
+1.13%+0.52%+27.20%+73.58% 7.06B
-0.96%-3.77%+191.56%+61.93% 4.44B
-2.45%-2.39%-14.90%-7.00% 2.84B
+0.25%+0.25%+29.57%+33.26% 2.7B
-4.41%-6.13%+13.94%+38.52% 2.5B
+0.10%-0.68%-16.31%+4.91% 1.95B
Average -0.36%-0.84%+25.13%+27.61% 10.35B
Weighted average by Cap. +0.16%-1.39%+3.86%-6.58%
See all sector performances

Financials

2025 *2026 *
Net sales 2,242B 1.53B 1.3B 1.22B 1.14B 2.1B 139B 2.3B 14.17B 5.48B 65.22B 5.73B 5.61B 237B 2,436B 1.66B 1.41B 1.32B 1.24B 2.28B 151B 2.5B 15.39B 5.95B 70.84B 6.23B 6.09B 258B
Net income 131B 89.29M 75.92M 71.04M 66.72M 123M 8.1B 134M 828M 320M 3.81B 335M 328M 13.86B 163B 111M 94.48M 88.41M 83.03M 153M 10.08B 167M 1.03B 398M 4.74B 417M 408M 17.25B
Net Debt -93.57B -63.74M -54.2M -50.72M -47.63M -87.75M -5.78B -95.88M -591M -229M -2.72B -239M -234M -9.9B -206B -141M -119M -112M -105M -193M -12.75B -211M -1.3B -504M -6B -527M -516M -21.82B
More financial data * Estimated data
Logo Yuhan Corporation
Yuhan Corp is a Korea-based company mainly engaged in the manufacture and sale of pharmaceuticals. The Company operates its business through three segments. The Pharmaceutical segment is engaged in the production and sale of non-prescription drugs including anti-inflammatory drugs, as well as prescription drugs such as drugs for hepatitis, diabetes, and hypertension. The Life and Health segment is involved in the production and sale of household goods and animal healthcare (AHC) products, including bleach, antibacterial agents. The Overseas Business segment supplies raw drugs to domestic and overseas markets. The Company also sells licenses. The Company distributes its products in domestic and overseas markets such as Europe, Asia and United States.
Employees
2,067
More about the company
Date Price Change Volume
25-12-15 116,700.00 -0.26% 279,194
25-12-12 117,000.00 +0.86% 287,451
25-12-11 116,000.00 +0.09% 424,947
25-12-10 115,900.00 -0.52% 199,445
25-12-09 116,500.00 +0.34% 228,450

End-of-day quote Korea S.E., December 14, 2025

More quotes
Trader
Investor
Global
Quality
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
116,700.00KRW
Average target price
148,388.89KRW
Spread / Average Target
+27.15%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A000100 Stock